Results 131 to 140 of about 10,096 (205)

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification. [PDF]

Front Oncol, 2023
Wieczorek A, Szewczyk K, Klekawka T, Stefanowicz J, Ussowicz M, Drabik G, Pawinska-Wasikowska K, Balwierz W.   +7 more
europepmc   +1 more source

Absence of MYCN Gene Amplification [PDF]

, 2020
openaire   +1 more source

Supplementary Figure 3 from Transcriptional Repression of <i>SKP2</i> Is Impaired in <i>MYCN</i>-Amplified Neuroblastoma [PDF]

, 2023
Daniel Rudolf Muth, Seda Ghazaryan, Isabella Eckerle, Emily Beckett, Christina Pöhler, Julia Batzler, Claudia Beisel, Sina Gogolin, Matthias Fischer, Kai‐Oliver Henrich, Volker Ehemann, Paul Gillespie, Manfred Schwab, Frank Westermann   +13 more
openalex   +1 more source

Table8_Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.XLSX

, 2021
Yuren Xia (11176598), Xin Li (51274), Xiangdong Tian (1720804), Qiang Zhao (105948)   +3 more
openalex   +2 more sources

Supplementary fig 3 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report

, 2023
Navin Pinto, Arlene Naranjo, Xiangming Ding, Fan F. Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong‐Michalak, David W. Craig, Zarko Manojlovic, Michael D. Hogarty, Susan G. Kreissman, Rochelle Bagatell, Meredith S. Irwin, Julie R. Park, Shahab Asgharzadeh   +15 more
openalex   +1 more source

Case Report: Complete remission in a neonate with high-risk neuroblastoma harboring MYCN amplification and 1p deletion: a case for aggressive early intervention, and literature review. [PDF]

Front Pediatr
Gabitova NK, Cherezova IN, Osipova IV, Sadykova DI, Nasr D, Gobarah AA, Arafat A.   +6 more
europepmc   +1 more source

Development of a prognostic model for overall survival in neuroblastoma based on Schwann cell-specific genes, clinical predictors, and MYCN amplification. [PDF]

Transl Cancer Res
Li Z, Liu J, Wu Y.
europepmc   +1 more source

Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastoma. [PDF]

J Immunother Cancer, 2021
Seier JA, Reinhardt J, Saraf K, Ng SS, Layer JP, Corvino D, Althoff K, Giordano FA, Schramm A, Fischer M, Hölzel M.   +10 more
europepmc   +1 more source

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis

, 2021
Kiyohiro Ando, Miki Ohira, Ichiro Takada, Verna Cázares‐Ordoñez, Yusuke Suenaga, Hiroki Nagase, Shinichi Kobayashi, Tsugumichi Koshinaga, Takehiko Kamijo, Makoto Makishima, Satoshi Wada   +10 more
openalex   +1 more source

Supplementary Figure Legend from The Coamplification Pattern of the <i>MYCN</i> Amplicon Is an Invariable Attribute of Most <i>MYCN</i>-Amplified Human Neuroblastomas

, 2023
Axel Weber, Sven Starke, Eckhard Bergmann, Holger Christiansen   +3 more
openalex   +1 more source